Phenotypes associated with this allele
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm3(CAG-flpo/ERT2)Alj mutation
(2 available);
any
Gt(ROSA)26Sor mutation
(942 available)
|
|
|
normal phenotype
|
• mice are viable and fertile with no reported phenotypic abnormalities
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm3(CAG-flpo/ERT2)Alj mutation
(2 available);
any
Gt(ROSA)26Sor mutation
(942 available)
Npm1tm1Trow mutation
(1 available);
any
Npm1 mutation
(33 available)
|
|
|
hematopoietic system
|
• increase in total number of colony forming units are found in whole bone marrow cells 4 months post-tamoxifen injection
|
|
• expansion of granulocyte and granulocyte-macrophage colony types are found in whole bone marrow cells 4 months post-tamoxifen injection
|
|
• decrease in frequency and total number of long term hematopoietic stem cells 4 months post-tamoxifen injection
• decrease in total number of short term hematopoietic stem cells 4 months post-tamoxifen injection
|
|
• bone marrow cells transplanted into lethally irradiated recipients and treated with pIpC and tamoxifen results in death in a 29% of animals in a 440 day period due to myeloproliferative disorder
|
hematopoietic system
|
• bone marrow cells transplanted into lethally irradiated recipients and treated with pIpC and tamoxifen results in death in a 100% of animals in a 440 day period
• in 33% of mice death is the result of myeloproliferative disorder (MPD)
• in 67% of mice death is the result of mixed myelodysplastic syndrome and myeloproliferative disorder (MDS/MPD)
• bone marrow cells from MDS/MPD or MPD primary transplants transplanted into sublethally irradiated secondary recipients results in 100% lethality due to acute myeloid leukemia (AML)
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm3(CAG-flpo/ERT2)Alj mutation
(2 available);
any
Gt(ROSA)26Sor mutation
(942 available)
Smarce1tm1Tich mutation
(0 available);
any
Smarce1 mutation
(28 available)
Smarce1tm2.1Tich mutation
(0 available);
any
Smarce1 mutation
(28 available)
Tg(Cd4-cre)1Cwi mutation
(10 available)
|
|
|
immune system
N |
• tamoxifen-treated mice exhibit no gross functional defects in mature T cells
|